Low prevalence of the transmitted HIV-1 drug resistance among newly diagnosed HIV-1 individuals in Jiangsu Province, China during 2009-2011. 2015

Hongxiong Guo, and Xiaoqin Xu, and Haiyang Hu, and Ying Zhou, and Haitao Yang, and Tao Qiu, and Gengfeng Fu, and Xiping Huan
Jiangsu Provincial Center for Disease Control and Prevention, 172 Jiangsu Road, Nanjing, 210009, China. hongxiongguo@gmail.com.

BACKGROUND Prevalence of The transmitted HIV drug resistance (THDR) has been reported in many countries. In China, the low level THDR was found in only a few provinces. To know the transmitted HIV drug resistance in east of China, we investigated THDR during 2009-2011 in Jiangsu province of China. METHODS Between January and August of 2009, 2010, and 2011, we consecutively collected 50, 54, 53 blood specimens respectively from qualified individuals at surveillance sentinel sites in Jiangsu province according to protocol of HIV Drug Resistance Threshold Survey (HIVDR-TS) recommended by WHO. The region of pol gene including protease and partial retro-transcriptase was amplified, sequenced and edited. Then the sequences were submitted to HIV drug resistance database to analysis transmitted HIV drug resistance mutations using Calibrated Population Resistance tool. The reference sequences of different HIV-1 subtypes were downloaded from HIV database and Genebank. The phylogenetic trees were inferred using the neighbor-joining method. RESULTS Our results show that THDR has been at low level from 2009 to 2011, only K101E and V179D mutation was detected which did not belong to the major HIV-1 drug resistance mutations. Phylogenetic analysis showed that CRF01_AE is the predominant subtype, and followed by CRF07_BC and B subtype. Subtype B consists of the two distinct clusters. CONCLUSIONS The low level of THDR suggests that anti-retroviral treatment was implemented more effectively and THDR surveillance should be conducted two years later in Jiangsu province of China. CRF01_AE has become the predominant subtype and dual infection of HIV may be common in Jiangsu province.

UI MeSH Term Description Entries
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012959 Socioeconomic Factors Social and economic factors that characterize the individual or group within the social structure. Economic and Social Factors,Social Inequalities,Social Inequality,Social and Economic Factors,Socioeconomic Characteristics,Factors, Socioeconomic,High-Income Population,Land Tenure,Standard of Living,Characteristic, Socioeconomic,Factor, Socioeconomic,High Income Population,High-Income Populations,Inequality, Social,Living Standard,Living Standards,Population, High-Income,Socioeconomic Characteristic,Socioeconomic Factor,Tenure, Land
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

Hongxiong Guo, and Xiaoqin Xu, and Haiyang Hu, and Ying Zhou, and Haitao Yang, and Tao Qiu, and Gengfeng Fu, and Xiping Huan
August 2023, AIDS research and human retroviruses,
Hongxiong Guo, and Xiaoqin Xu, and Haiyang Hu, and Ying Zhou, and Haitao Yang, and Tao Qiu, and Gengfeng Fu, and Xiping Huan
December 2010, Journal of medical virology,
Hongxiong Guo, and Xiaoqin Xu, and Haiyang Hu, and Ying Zhou, and Haitao Yang, and Tao Qiu, and Gengfeng Fu, and Xiping Huan
December 2020, Journal of medical virology,
Hongxiong Guo, and Xiaoqin Xu, and Haiyang Hu, and Ying Zhou, and Haitao Yang, and Tao Qiu, and Gengfeng Fu, and Xiping Huan
January 2017, PloS one,
Hongxiong Guo, and Xiaoqin Xu, and Haiyang Hu, and Ying Zhou, and Haitao Yang, and Tao Qiu, and Gengfeng Fu, and Xiping Huan
August 2018, Scientific reports,
Hongxiong Guo, and Xiaoqin Xu, and Haiyang Hu, and Ying Zhou, and Haitao Yang, and Tao Qiu, and Gengfeng Fu, and Xiping Huan
April 2011, AIDS (London, England),
Hongxiong Guo, and Xiaoqin Xu, and Haiyang Hu, and Ying Zhou, and Haitao Yang, and Tao Qiu, and Gengfeng Fu, and Xiping Huan
January 2018, PloS one,
Hongxiong Guo, and Xiaoqin Xu, and Haiyang Hu, and Ying Zhou, and Haitao Yang, and Tao Qiu, and Gengfeng Fu, and Xiping Huan
December 2021, China CDC weekly,
Hongxiong Guo, and Xiaoqin Xu, and Haiyang Hu, and Ying Zhou, and Haitao Yang, and Tao Qiu, and Gengfeng Fu, and Xiping Huan
January 2010, AIDS research and human retroviruses,
Hongxiong Guo, and Xiaoqin Xu, and Haiyang Hu, and Ying Zhou, and Haitao Yang, and Tao Qiu, and Gengfeng Fu, and Xiping Huan
February 2011, Southern medical journal,
Copied contents to your clipboard!